Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study.
Adam J OlszewskiTycel Jovelle PhillipsMarc S HoffmannPhilippe ArmandTae Min KimDok Hyun YoonAmitkumar MehtaRichard GreilJason R WestinIzidore S LossosJavier L MuñozJason SitMichael C WeiAnnie YangVivian ChenEnkhtsetseg PurevDonald L YeeUlrich JägerPublished in: Blood advances (2023)
Please note that the abstract has been provided separately as it is now over the word count due to the incorporation of reviewer suggestions.